5408-1622 Screening compound: N'-[(3Z)-5-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide

5408-1622 Screening compound: N'-[(3Z)-5-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide
5408-1622 Screening compound: N'-[(3Z)-5-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide alternative view

Chemical Structure Depiction of ChemDiv screening compound 5408-1622
N'-[(3Z)-5-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5408-1622

Molecular Formula

C25H21BrN4O2 (C25 H21 BrN4 O2)

Compound Name

N'-[(3Z)-5-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide

IUPAC name

N'-[(3Z)-5-bromo-2-oxo-23-dihydro-1H-indol-3-ylidene]-4-[(1234-tetrahydroisoquinolin-2-yl)methyl]benzohydrazide

SMILES

O=C(c1ccc(CN(CC2)Cc3c2cccc3)cc1)N/N=C(/c(cc(cc1)Br)c1N1)\C1=O

InChI

InChI=1S/C25H21BrN4O2/c26-20-9-10-22-21(13-20)23(25(32)27-22)28-29-24(31)18-7-5-16(6-8-18)14-30-12-11-17-3-1-2-4-19(17)15-30/h1-10,13H,11-12,14-15H2,(H,29,31)(H,27,28,32)

InChI Key

KWASKAPCRLTCNC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04077797

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

489.37

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.737

Distribution Coefficient, logD

4.034

Water Solubility, LogSw

-4.66

Polar Surface Area

62.759

Acid Dissociation Constant (pKa)

6.79

Base Dissociation Constant (pKb)

7.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.00

5408-1622 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 5408-1622 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5408-1622?
Check Price and Availability of 5408-1622, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5408-1622 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5408-1622
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5408-1622
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5408-1622 available by request